VIEWS DECISIONS 1 (S-X), 2 (S-X), 3 (S-X), 4 (S-X) AND 5 (S-X) OF THE UNITED NATIONS DRUG COMMISSION, ADOPTED AT ITS 994 A. SESSION, HELD ON 8 FEBRUARY 1988 AND COMMUNICATED BY THE SECRETARY-GENERAL OF THE UNITED NATIONS ON 15 APRIL 1988, BY VIRTUE OF THE REPORTS AND RECOMMENDATIONS RECEIVED FROM THE WORLD HEALTH ORGANIZATION, TO INCLUDE THE SUBSTANCES SUBSEQUENTLY LISTED IN THE LISTS ANNEXED TO THE SINGLE CONVENTION ON NARCOTIC DRUGS DRAWN UP AT THE UNITED NATIONS CONFERENCE, HELD AT THE UN HEADQUARTERS, ON 24 MARCH JANUARY AT 25 MARCH 1961 AND RATIFIED BY SPAIN BY MEANS OF INSTRUMENT OF 3 FEBRUARY 1966, PUBLISHED IN THE OF 22 APRIL 1966 AND SUBSEQUENTLY AMENDED BY THE PROTOCOL OF 25 MARCH 1972, RATIFIED FOR SPAIN BY MEANS OF INSTRUMENT OF 15 DECEMBER 1976, PUBLISHED IN OF 15 FEBRUARY 1977.

TAKING INTO ACCOUNT THE PROVISIONS OF PARAGRAPHS 3 (III) AND 5 OF ARTICLE 3. OF THE SAID SINGLE CONVENTION AND UNDER THE POWERS CONFERRED IN THE FIRST CHAPTER, SECOND ARTICLE, PARAGRAPHS 1 AND 2 OF LAW 17/1967 OF 8 APRIL ON NARCOTIC DRUGS,

THIS MINISTRY HAS HAD WELL TO DISPOSE:

FIRST. INCLUDE IN LISTS I AND IV ANNEXED TO THE 1961 SINGLE CONVENTION ON NARCOTIC DRUGS AND OF THAT CONVENTION AS AMENDED BY THE 1972 PROTOCOL THE SUBSTANCES:

ACETYL-ALPHA-METHYL-FENTANYL, OF FORMULA N-(1-(-METHYLPHENYL) -4-PIPERIDYL) ACETANILIDE.

ALPHA-METHYLFENTANYL, OF FORMULA N-(1-(-METHYLPHENETHYL) -4-PIPERIDYL) PROPIONANILIDE.

3-METHYLFENTANYL, OF FORMULA N-(3 METHYL-1-PHENETHYL-4-PIPERIDYL) PROPIONANILIDE IN ITS TWO ISOMERIC FORMS.

PEPAP, OF FORMULA 1-PHENETHYL-4 PHENYL-4-ACETATE PIPERIDINE (ESTER).

MPPP, OF PIPERIDINE FORMULA 1-METHYL-4-PHENYL-4-PROPIONATE (ESTER).

SECOND. THE FIVE ABOVE SUBSTANCES, AS WELL AS ALL SALTS THEREOF, WHICH MAY BE FORMED FROM SUCH SUBSTANCES, MAY NOT BE THE SUBJECT OF PRODUCTION, MANUFACTURE, EXPORT AND IMPORT, TRADE, POSSESSION OR USE, WITH THE EXCEPTION OF THE QUANTITIES NECESSARY FOR MEDICAL AND SCIENTIFIC RESEARCH, INCLUDING CLINICAL EXPERIMENTS WITH SUCH DRUGS TO BE CARRIED OUT UNDER THE SUPERVISION AND SUPERVISION OF THE GENERAL DIRECTORATE OF PHARMACY AND MEDICAL DEVICES.

THIRD. THE ENTITIES WHICH HOLD OR ARE IMPORTERS OR MANUFACTURERS OF THE FOREGOING SUBSTANCES, AT THE ENTRY INTO FORCE OF THIS ORDER, SHALL PROCEED TO DECLARE AND DELIVER THEM TO THE GENERAL DIRECTORATE OF PHARMACY AND MEDICAL DEVICES.

FOURTH. THIS ORDER WILL TAKE EFFECT THE DAY AFTER YOUR PUBLICATION IN THE .

MADRID, DECEMBER 20, 1988.

GARCIA VARGAS

ILMO. MR. DIRECTOR GENERAL OF PHARMACY AND MEDICAL DEVICES.